Skip to main navigation

Home

Pipeline +

Overview

Complement Mediated Diseases

Compassionate Use Policy

Our Science +

Overview

Resources

Patients and Clinicians

About Achillion +

Overview

Leadership

Board of Directors

Business Development

Investors & News +

Overview

Stock Information

Press Releases

Events & Presentations

Annual Reports

Financial Information

Corporate Governance

FAQs

Contact Us

Connect

Join Us +

Life at Achillion

Opportunities

Legal

Privacy

Cookies

Achillion Pharmaceuticals

INVESTORS

Press Releases

Category:

Year:

Items per page

There are currently no news releases to display.

Pagination

First page
Previous page
…
Page 4
Page 5
Page 6
Current page 7

Displaying 61 - 70 of 70 results

Investor Relations

Investor Overview
Events & Presentations
Press Releases
Financial Reports
SEC Filings
Annuals and Proxies
Stock Information
Analyst Coverage
Corporate Governance
Board of Directors
Investor FAQs
Contact Us
Email Alerts

Shareholder Tools

Printed Materials
Email Alerts
Downloads
RSS
Print
Share
Search

Facebook
Google
LinkedIn
Twitter
RSS

Search

Home

Pipeline

Our Science

Patients and
Clinicians

Achillion Pharmaceuticals, Inc.

300 George Street

New Haven, CT 06511

main 203.624.7000

1777 Sentry Parkway West
VEVA Building #14, Suite 404
Blue Bell, Pennsylvania 19422